I've been looking at a few industry reports on the future of biopharma as part of a course I'm on with INSEAD Business School on Business Strategy and Financial Performance. I thought I'd share some of my ramblings on Biopharma Futures. Expectations are high Pharmaceutical
companies are operating...
Source: deanjenkins.me
The COVID-19 pandemic has accelerated changes to our working world. What does this mean for pharma, and what must the industry do to keep pace? PwC - future of work for pharma costs - pressures on efficienct, increasing R&D costs sustainability and societal impact - pressure on companies to address...
Source: pwc.co.uk
A critical makeover for pharmaceutical companies: Overcoming industry obstacles with a cross-functional strategy. PwC report. Going all "cross-functional" or "breaking down silos"?
"Compounding the external obstacles, however, is the internal culture of most pharma companies. This is an industry...
Source: pwc.com